Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:18641035rdf:typepubmed:Citationlld:pubmed
pubmed-article:18641035lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:18641035lifeskim:mentionsumls-concept:C0008976lld:lifeskim
pubmed-article:18641035lifeskim:mentionsumls-concept:C0015677lld:lifeskim
pubmed-article:18641035lifeskim:mentionsumls-concept:C0028621lld:lifeskim
pubmed-article:18641035lifeskim:mentionsumls-concept:C0035379lld:lifeskim
pubmed-article:18641035lifeskim:mentionsumls-concept:C1704711lld:lifeskim
pubmed-article:18641035lifeskim:mentionsumls-concept:C0040808lld:lifeskim
pubmed-article:18641035lifeskim:mentionsumls-concept:C0205265lld:lifeskim
pubmed-article:18641035lifeskim:mentionsumls-concept:C1705241lld:lifeskim
pubmed-article:18641035lifeskim:mentionsumls-concept:C1704419lld:lifeskim
pubmed-article:18641035lifeskim:mentionsumls-concept:C1555582lld:lifeskim
pubmed-article:18641035lifeskim:mentionsumls-concept:C1705242lld:lifeskim
pubmed-article:18641035pubmed:issue4lld:pubmed
pubmed-article:18641035pubmed:dateCreated2008-9-17lld:pubmed
pubmed-article:18641035pubmed:databankReferencehttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18641035pubmed:abstractTextThe aim of this study was to evaluate the impact on body fat of nucleoside reverse transcriptase inhibitor (NRTI)-sparing regimens compared with NRTI-containing therapy in HIV-1-infected antiretroviral (ARV)-naive patients.lld:pubmed
pubmed-article:18641035pubmed:languageenglld:pubmed
pubmed-article:18641035pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18641035pubmed:citationSubsetIMlld:pubmed
pubmed-article:18641035pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18641035pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18641035pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18641035pubmed:statusMEDLINElld:pubmed
pubmed-article:18641035pubmed:monthOctlld:pubmed
pubmed-article:18641035pubmed:issn1460-2091lld:pubmed
pubmed-article:18641035pubmed:authorpubmed-author:KatlamaChrist...lld:pubmed
pubmed-article:18641035pubmed:authorpubmed-author:CalvezVincent...lld:pubmed
pubmed-article:18641035pubmed:authorpubmed-author:CostagliolaDo...lld:pubmed
pubmed-article:18641035pubmed:authorpubmed-author:PeytavinGille...lld:pubmed
pubmed-article:18641035pubmed:authorpubmed-author:MolinaJean-Mi...lld:pubmed
pubmed-article:18641035pubmed:authorpubmed-author:GhosnJadeJlld:pubmed
pubmed-article:18641035pubmed:authorpubmed-author:DuvivierClaud...lld:pubmed
pubmed-article:18641035pubmed:authorpubmed-author:BouchaudOlivi...lld:pubmed
pubmed-article:18641035pubmed:authorpubmed-author:SouliéCathiaClld:pubmed
pubmed-article:18641035pubmed:authorpubmed-author:AssoumouLambe...lld:pubmed
pubmed-article:18641035pubmed:authorpubmed-author:GéninMichèle...lld:pubmed
pubmed-article:18641035pubmed:authorpubmed-author:ANRS 121...lld:pubmed
pubmed-article:18641035pubmed:issnTypeElectroniclld:pubmed
pubmed-article:18641035pubmed:volume62lld:pubmed
pubmed-article:18641035pubmed:ownerNLMlld:pubmed
pubmed-article:18641035pubmed:authorsCompleteYlld:pubmed
pubmed-article:18641035pubmed:pagination797-808lld:pubmed
pubmed-article:18641035pubmed:meshHeadingpubmed-meshheading:18641035...lld:pubmed
pubmed-article:18641035pubmed:meshHeadingpubmed-meshheading:18641035...lld:pubmed
pubmed-article:18641035pubmed:meshHeadingpubmed-meshheading:18641035...lld:pubmed
pubmed-article:18641035pubmed:meshHeadingpubmed-meshheading:18641035...lld:pubmed
pubmed-article:18641035pubmed:meshHeadingpubmed-meshheading:18641035...lld:pubmed
pubmed-article:18641035pubmed:meshHeadingpubmed-meshheading:18641035...lld:pubmed
pubmed-article:18641035pubmed:meshHeadingpubmed-meshheading:18641035...lld:pubmed
pubmed-article:18641035pubmed:meshHeadingpubmed-meshheading:18641035...lld:pubmed
pubmed-article:18641035pubmed:meshHeadingpubmed-meshheading:18641035...lld:pubmed
pubmed-article:18641035pubmed:meshHeadingpubmed-meshheading:18641035...lld:pubmed
pubmed-article:18641035pubmed:meshHeadingpubmed-meshheading:18641035...lld:pubmed
pubmed-article:18641035pubmed:meshHeadingpubmed-meshheading:18641035...lld:pubmed
pubmed-article:18641035pubmed:meshHeadingpubmed-meshheading:18641035...lld:pubmed
pubmed-article:18641035pubmed:meshHeadingpubmed-meshheading:18641035...lld:pubmed
pubmed-article:18641035pubmed:meshHeadingpubmed-meshheading:18641035...lld:pubmed
pubmed-article:18641035pubmed:meshHeadingpubmed-meshheading:18641035...lld:pubmed
pubmed-article:18641035pubmed:meshHeadingpubmed-meshheading:18641035...lld:pubmed
pubmed-article:18641035pubmed:year2008lld:pubmed
pubmed-article:18641035pubmed:articleTitleInitial therapy with nucleoside reverse transcriptase inhibitor-containing regimens is more effective than with regimens that spare them with no difference in short-term fat distribution: Hippocampe-ANRS 121 Trial.lld:pubmed
pubmed-article:18641035pubmed:affiliationAP-HP, Groupe hospitalier Pitié-Salpétrière, Service de Maladies Infectieuses et Tropicales, Paris F-75013, France.lld:pubmed
pubmed-article:18641035pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:18641035pubmed:publicationTypeRandomized Controlled Triallld:pubmed
pubmed-article:18641035pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
pubmed-article:18641035pubmed:publicationTypeMulticenter Studylld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18641035lld:pubmed